Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer

NCT06793579 | Completed

• 1 other identifier: YAN-1
• Study Type: observational
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

Despite the numerous surgical approaches available for superior mediastinal lymph node dissection in thyroid cancer, many of these methods still have significant limitations. In this study, we report for the first time a novel surgical technique for superior mediastinal lymph node dissection: a thyroid cancer surgery based on a lateral cervical approach. This technique offers a new surgical option for the dissection of superior mediastinal lymph nodes in thyroid cancer.

Conditions

Thyroid Cancer; Mediastinal Diseases; Lymph Node Metastasis

Outcome Measures

Primary Outcomes (5)

• Number of upper mediastinal lymph nodes dissected

  Postoperative pathological records

  1day

• Duration of surgery

  Described in the surgical record

  1day

• Postoperative complications

  According to the follow-up data

  1 month

• Surgical blood loss

  Described in the surgical record

  1day

• Postoperative hospital stay

  Recorded in medical records

  1week

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The subjects of this retrospective study were all patients in our department who underwent treatment with this surgical approach during the inclusion period.

You may qualify if:

• All patients who underwent thyroid cancer superior mediastinal lymph node dissection via the lateral cervical approach in our department.
• Complete hospitalization records, ensuring that the patient's surgical records, pathological examinations, and other information are fully traceable.
• Complete postoperative follow-up data, including complications during the follow-up period.
• No other severe comorbidities, to avoid surgical outcome bias caused by other diseases.
• No distant metastasis found preoperatively, or distant metastasis is still assessable for effective treatment.

You may not qualify if:

• Cases with incomplete data, such as missing hospitalization records or incomplete follow-up data.
• Systemic diseases with severe heart, lung, liver, kidney, or brain dysfunction that may affect the accuracy of data.
• Patients with severe coagulopathy.
• Tumor pathology indicating undifferentiated thyroid cancer, malignant lymphoma, or non-thyroid-origin tumors.

Sponsors & Collaborators

• Chongqing General Hospital: lead

Study Sites (1)

Chongqing General Hospital

Chongqing, Chongqing Municipality, 400000, China

Location

MeSH Terms

Conditions

Thyroid Neoplasms; Mediastinal Diseases; Lymphatic Metastasis

Condition Hierarchy (Ancestors)

Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Head and Neck Neoplasms; Endocrine System Diseases; Thyroid Diseases; Thoracic Diseases; Respiratory Tract Diseases; Neoplasm Metastasis; Neoplastic Processes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 21, 2025
• First Posted: January 27, 2025
• Study Start: January 1, 2024
• Primary Completion: January 20, 2025
• Study Completion: January 20, 2025
• Last Updated: January 27, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)